This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1988 Aug;58(2):186-8.

doi: 10.1038/bjc.1988.189.

Matrix heparan sulphate, but not endothelial cell surface heparan sulphate, is degraded by highly metastatic mouse lymphoma cells

R Hennes¹, F Frantzen, R Keller, V Schirrmacher, R Schwartz-Albiez

Affiliations

PMID: 2971387
PMCID: PMC2246756
DOI: 10.1038/bjc.1988.189

Free PMC article

Matrix heparan sulphate, but not endothelial cell surface heparan sulphate, is degraded by highly metastatic mouse lymphoma cells

R Hennes et al. Br J Cancer. 1988 Aug.

Free PMC article

. 1988 Aug;58(2):186-8.

doi: 10.1038/bjc.1988.189.

Authors

R Hennes¹, F Frantzen, R Keller, V Schirrmacher, R Schwartz-Albiez

Affiliation

¹ Department of Clinical Chemistry and Pathobiochemistry, Aachen Technical University, FRG.

PMID: 2971387
PMCID: PMC2246756
DOI: 10.1038/bjc.1988.189

No abstract available

PubMed Disclaimer

Similar articles

Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines.
Nakajima M, Irimura T, Di Ferrante D, Di Ferrante N, Nicolson GL. Nakajima M, et al. Science. 1983 May 6;220(4597):611-3. doi: 10.1126/science.6220468. Science. 1983. PMID: 6220468
Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.
Saksela O, Rifkin DB. Saksela O, et al. J Cell Biol. 1990 Mar;110(3):767-75. doi: 10.1083/jcb.110.3.767. J Cell Biol. 1990. PMID: 2137829 Free PMC article.
Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
Marchetti D. Marchetti D. J Cell Physiol. 1997 Sep;172(3):334-42. doi: 10.1002/(SICI)1097-4652(199709)172:3<334::AID-JCP7>3.0.CO;2-P. J Cell Physiol. 1997. PMID: 9284953
Heparan sulphate proteoglycans.
Gallagher JT, Turnbull JE, Lyon M. Gallagher JT, et al. Biochem Soc Trans. 1990 Apr;18(2):207-9. doi: 10.1042/bst0180207. Biochem Soc Trans. 1990. PMID: 2143154 Review. No abstract available.
Proteoglycans: structure, function, and role in neoplasia.
Iozzo RV. Iozzo RV. Lab Invest. 1985 Oct;53(4):373-96. Lab Invest. 1985. PMID: 2413275 Review. No abstract available.

See all similar articles

Cited by

Human platelet heparanase: purification, characterization and catalytic activity.
Freeman C, Parish CR. Freeman C, et al. Biochem J. 1998 Mar 15;330 ( Pt 3)(Pt 3):1341-50. doi: 10.1042/bj3301341. Biochem J. 1998. PMID: 9494105 Free PMC article.

References

1. Annu Rev Biochem. 1978;47:385-417 - PubMed
1. Int J Cancer. 1979 Feb;23(2):233-44 - PubMed
1. Eur J Immunol. 1982 Apr;12(4):300-7 - PubMed
1. J Exp Med. 1983 Jan 1;157(1):371-6 - PubMed
1. Cancer Immunol Immunother. 1982;13(1):62-8 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information